ABSTRACT
Multisource pharmaceutical products are intended to be pharmaceutically equivalent or pharmaceutical alternatives that are bioequivalent and hence are therapeutically equivalent and interchangeable. Thus, this study was aimed at carrying out a comparative in-vitro and in-vivo bioequivalence studies of some brands of Metronidazole (200 mg) tablets marketed in Zaria, Nigeria. BP 2002 method was use for the assessment of the pharmaceutical and chemical equivalences of the samples of metronidazole tablets. Tablet hardness and friability testing were also carried out to reinforce the official methods for the in vitro studies. The analytical method for the in vivo studies was adopted from the work of Kolawole and Ameh (2004). The method was validated according to ICH/WHO guideline. Six healthy human volunteers were enrolled for the studies according to the normal protocols for bioequivalence studies. The study yielded the following results: The presence of metronidazole was observed in all the samples with a content uniformity of 92.45 - 106.16 %. All the samples had acceptable level of weight variation, except MT05, MT08 and MT12 with 5, 4 and 14 tablets respectively deviated from the mean weight. All the samples disintegrated within 15 minutes (BP specification) with the exception of MT07 which disintegrated in 18.97 minutes. Each of the samples had at least a dissolution of 70 % within 45 minutes. All the samples had acceptable level of friability, except MT05, MT07, MT08 and MT11 with value of 1.70 %, 1.81 %, 1.62 % and 10.25 % respectively above the 1 % acceptable limit. All the samples of the tablets had acceptable hardness within the limit of 4-10 kgF, except MT10 and MT11 with a value of 10.70 kgF and 10.6 kgF respectively. The validated method was found to have an intra- and inter-day precision of 0.491 and 0.417 % respectively expressed as percentage relative standard deviation. The accuracy of the method was 1.98 % with a mean percentage recovery of 98.3 %. All the samples had acceptable level of bioequivalence xiv within the range of 0.93-1.05 with reference to MT01® as the reference standard using point estimate ratio of the mean Cmax and AUC0→8h /µg. In conclusion, the samples of the metronidazole 200 mg tablets analysed can be used interchangeably even though there was some variation in their pharmaceutical equivalences.
Background of the Study
The equitable distribution of state allocations is a critical aspect of resourc...
Background of the Study
E-commerce has transformed the retail industry globally, offering convenience, wider reach, and accessibility to...
ABSTRACT
This study examined the influence of public relations practice on information service delivery and librarians’ image in fe...
Background of the Study
Aflatoxins are toxic metabolites produced by certain fungi that commonly contaminate stored grains,...
Background of the Study
In August 2019, President Muhammadu Buhari's administration closed Nigeria’s land borders...
Background of the Study
Farmers in rural Nigeria rely heavily on credit facilities to finance their agricultural activitie...
Background of the Study
Sustainable property development has gained significant attention in recent years, with its emphasis on minimizin...
EXCERPT FROM THE STUDY
Background of the Study
Knowledge management systems (KMS) are integral to modern organizations, enabling them to captur...
Background of the Study
Whistleblower protection laws are critical for the detection and prevention of corporate fraud,...